Cargando…

Dealing with a new disease

Detalles Bibliográficos
Autor principal:	Pinto, Y. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2022
Materias:	Editor’s Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589729/ https://www.ncbi.nlm.nih.gov/pubmed/36279085 http://dx.doi.org/10.1007/s12471-022-01727-2

Ejemplares similares

Double dealing
Publicado: (1997)

How to deal with hypertension in the COVID-19 era—the impact “ON” and “OF” hypertension
por: Ishida, Mari
Publicado: (2021)

Seeing the disease before it has manifested itself
por: Pinto, Y.
Publicado: (2019)

Three decades of heart transplantation in the Netherlands
por: Pinto, Y. M.
Publicado: (2017)

Towards evidence-based management of patients treated with cardiotoxic chemotherapy: A collaborative effort of cardiologists and oncologists
por: Leerink, J. M., et al.
Publicado: (2018)

‘I tested positive, so do I have the condition or not?’
por: Delewi, R., et al.
Publicado: (2021)

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
por: Walsh, R., et al.
Publicado: (2021)

Non-obstructive cardiovascular disease: a new challenge for invasive cardiology?
por: Wittekoek, M. E., et al.
Publicado: (2017)

“When you see a fork in the road, take it”—Yogi Berra
por: Pinto, Yigal M., et al.
Publicado: (2023)

Individual, societal and clinical burden of cardiovascular disease: health technology assessment to guide new diagnostics and treatment strategies
por: van der Velden, Jolanda
Publicado: (2023)

Mpox: a new name for a new disease?
por: Beaumont, Anne-Lise, et al.
Publicado: (2023)

Dealing with the Problem of Monotone Likelihood in the Inflation of Estimated Effects in Clinical Studies. Comment on Hasegawa et al. Impact of Blood Type O on Mortality of Sepsis Patients: A Multicenter Retrospective Observational Study. Diagnostics 2020, 10, 826
por: Tzeng, I-Shiang
Publicado: (2022)

New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?
por: van der Wall, E. E.
Publicado: (2014)

The new Editorial Board
por: Piek, J. J.
Publicado: (2016)

The Aftermath of Bariatric Surgery: Can the Average Emergency Surgeon Deal with Its Complications? Comment on Zawadzka et al. Current Knowledge and Perceptions of Bariatric Surgery among Diabetologists and Internists in Poland. J. Clin. Med. 2022, 11, 2028
por: Papageorgopoulou, Chrysanthi, et al.
Publicado: (2022)

New therapies to treat inherited cardiomyopathies are on the way
por: Vlasman, P., et al.
Publicado: (2022)

Improvement in CRT: new strategies, better choices
por: van der Wall, E. E.
Publicado: (2014)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

Conflicts of interest: call for new editorial policies in European national journals
por: van der Wall, E. E.
Publicado: (2012)

New insights in prevention, diagnosis and treatment of stroke: its relation with atrial fibrillation
por: van der Wall, E. E.
Publicado: (2012)

The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2019)

Cardiac disease and depression; a direct association?
por: van der Wall, E. E.
Publicado: (2016)

Middle East respiratory syndrome: new disease, old lessons
por: Gomersall, Charles D, et al.
Publicado: (2013)

Playing catch with long COVID – Understanding a new disease
por: Berg, Selina Kikkenborg, et al.
Publicado: (2022)

Climate change and infectious disease: time for a new normal?
por: Heffernan, Claire
Publicado: (2015)

Does post COVID-19 characterize new diseases and disabilities?
por: Chakrovorty, Sonjit Kumar, et al.
Publicado: (2023)

Noninvasive prenatal testing complicated by maternal malignancy: new tools for a complex problem
por: Lo, Y M Dennis
Publicado: (2016)

Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
por: d’Arminio Monforte, Antonella, et al.
Publicado: (2020)

Multifocal cerebellar liponeurocytoma: How to deal with it?
por: Ghedira, Khalil, et al.
Publicado: (2023)

Guidance of interventions in structural heart disease; three-dimensional techniques are here to stay
por: Voskuil, M., et al.
Publicado: (2017)

Dealing of mass casualty in ophthalmology - A challenge
por: Pandey, Kalpana, et al.
Publicado: (2010)

The pathophysiology of Peyronie's disease: beyond the Smith's space
Publicado: (2015)

Phasing out monkeypox: mpox is the new name for an old disease
por: Damaso, Clarissa R.
Publicado: (2022)

Productivity-adjusted life-years: new measure of disease burden
Publicado: (2021)

Stem cell therapy for heart disease: truly beneficial?
por: van der Wall, E. E.
Publicado: (2014)

Beta-blocking agents in cardiovascular disease; are they here to stay?
por: van der Wall, E. E.
Publicado: (2014)

Health literacy skills and the benefits of cardiovascular disease prevention
por: Peters, R. J. G.
Publicado: (2017)

The PROMISE study: a clear promise for functional stress testing in patients with suspected coronary artery disease
por: van der Wall, E.E.
Publicado: (2015)

Screening in asymptomatic coronary artery disease: helpful, redundant or harmful?
por: van der Wall, E. E.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mi870fraviovlj09ctk8qop2p0